£100M boost for UK healthtech as British Business Bank backs Apposite growth fund
Summary
The British Business Bank has committed £100 million to Apposite Healthcare Growth I, marking its largest fund commitment to date and its first with specialist investor Apposite Capital. This fund will primarily target high-growth UK health technology companies across medical products, diagnostics, life sciences tools, digital health, and pharmaceutical outsourcing services. The initiative aims to address the persistent shortage of scale-up capital for UK life sciences firms, aligning with the Bank's strategy to deepen growth-stage funding pools. As a cornerstone investor, the British Business Bank seeks to mobilize private sector investment and support the launch of new growth-stage funds. Ultimately, this investment will enable innovative UK companies to accelerate growth, commercialize transformative technologies, improve health outcomes, and create highly skilled jobs.
Key takeaway
The British Business Bank has committed £100M to Apposite Healthcare Growth I, its largest fund commitment, to address the critical shortage of scale-up capital for UK healthtech. This cornerstone investment will back high-growth UK life sciences companies across medical products, diagnostics, and digital health, aiming to mobilize further private capital. The initiative seeks to deepen the UK's late-stage funding pool, enabling innovators to scale globally, improve patient outcomes, and create skilled jobs.
Topics
- British Business Bank
- Apposite Capital
- UK Healthtech
- Life Sciences Investment
- Scale-up Funding
Best for: Investor, Entrepreneur, Executive
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Tech.eu - Tech.eu.